Literature DB >> 20007812

CD44: target for antiangiogenesis therapy.

Horace M DeLisser1.   

Abstract

Entities:  

Year:  2009        PMID： 20007812     DOI： 10.1182/blood-2009-10-246397

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  55 in total

Review 1.  ITAMs versus ITIMs: striking a balance during cell regulation.

Authors:  Daniel D Billadeau; Paul J Leibson
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 2.  The making of filopodia.

Authors:  Jan Faix; Klemens Rottner
Journal:  Curr Opin Cell Biol       Date:  2005-12-06       Impact factor: 8.382

3.  Gene targeting of Cdc42 and Cdc42GAP affirms the critical involvement of Cdc42 in filopodia induction, directed migration, and proliferation in primary mouse embryonic fibroblasts.

Authors:  Linda Yang; Lei Wang; Yi Zheng
Journal:  Mol Biol Cell       Date:  2006-08-16       Impact factor: 4.138

4.  Targeting PECAM-1 for anti-cancer therapy.

Authors:  Horace M Delisser
Journal:  Cancer Biol Ther       Date:  2007-01       Impact factor: 4.742

5.  Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression.

Authors:  J Sun; J Williams; H C Yan; K M Amin; S M Albelda; H M DeLisser
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

6.  Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis.

Authors:  Anna Solowiej; Purba Biswas; Donnasue Graesser; Joseph A Madri
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

7.  ERK and RhoA differentially regulate pseudopodia growth and retraction during chemotaxis.

Authors:  Anar A Brahmbhatt; Richard L Klemke
Journal:  J Biol Chem       Date:  2003-02-05       Impact factor: 5.157

8.  Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor.

Authors:  Yuan Ren; Songshu Meng; Lin Mei; Z Joe Zhao; Richard Jove; Jie Wu
Journal:  J Biol Chem       Date:  2003-12-08       Impact factor: 5.157

9.  Platelet/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans.

Authors:  H M DeLisser; H C Yan; P J Newman; W A Muller; C A Buck; S M Albelda
Journal:  J Biol Chem       Date:  1993-07-25       Impact factor: 5.157

10.  Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates.

Authors:  C T Hua; J R Gamble; M A Vadas; D E Jackson
Journal:  J Biol Chem       Date:  1998-10-23       Impact factor: 5.157
View more
  4 in total

1.  An easy method to detect the kinetics of CD44 antibody and its receptors on B16 cells using atomic force microscopy.

Authors:  Hua Jin; Hongxia Zhao; Xianxian Chen; Lina Ma; Xun Huang; Hongyan Ye; Jiye Cai
Journal:  Mol Biol Rep       Date:  2010-12-08       Impact factor: 2.316

2.  Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas.

Authors:  Nina Shah; Fernando Cabanillas; Bradley McIntyre; Lei Feng; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; Anas Younes; Fredrick B Hagemeister; Larry Kwak; Luis Fayad
Journal:  Leuk Lymphoma       Date:  2011-10-24

3.  Androgen Receptor Regulates CD44 Expression in Bladder Cancer.

Authors:  Joseph L Sottnik; Lauren Vanderlinden; Molishree Joshi; Ana Chauca-Diaz; Charles Owens; Donna E Hansel; Colin Sempeck; Debashis Ghosh; Dan Theodorescu
Journal:  Cancer Res       Date:  2021-03-09       Impact factor: 13.312

4.  PROGNOSTIC ROLE OF CD44 EXPRESSION AND NEOVASCULARIZATION DETERMINED BY ENDOGLIN (CD105) IN GLIOBLASTOMA PATIENTS.

Authors:  Josip Mihić; Krešimir Rotim; Majda Vučić; Ida Hude Dragičević; Marta Borić; Liborija Lugović-Mihić
Journal:  Acta Clin Croat       Date:  2019-09       Impact factor: 0.932
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.